Keyword Analysis & Research: bristol myers squibb website
Keyword Research: People who searched bristol myers squibb website also searched
Search Results related to bristol myers squibb website on Search Engine
-
Global Biopharmaceutical Company - Bristol Myers Squibb
https://www.bms.com/
WebBristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases. website
website
DA: 52 PA: 45 MOZ Rank: 5
-
About us - Bristol Myers Squibb
https://www.bms.com/about-us.html
WebWe promote health equity and seek to improve the health outcomes of populations disproportionately affected by serious diseases. Learn about global biopharmaceutical innovator Bristol Myers Squibb, helping millions to fight cancer, cardiovascular disease, HIV/AIDS, and more.
DA: 30 PA: 98 MOZ Rank: 37
-
Products and medicines - Bristol Myers Squibb
https://www.bms.com/patient-and-caregivers/our-medicines.html
WebBristol Myers Squibb focuses on developing new medicines to address the unmet medical needs of patients with serious diseases. Explore comprehensive information about our products including dosage and safety information.
DA: 35 PA: 95 MOZ Rank: 6
-
Your Meaningful Career at Bristol Myers Squibb
https://careers.bms.com/
WebDiscover what it means to have a meaningful career. At Bristol Myers Squibb, you'll transform patients' lives and help them prevail over serious diseases.
DA: 3 PA: 87 MOZ Rank: 67
-
Bristol Myers Squibb - Wikipedia
https://en.wikipedia.org/wiki/Bristol_Myers_Squibb
WebThe Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
DA: 97 PA: 77 MOZ Rank: 66
-
Medical information for healthcare providers - Bristol Myers Squibb
https://www.bms.com/healthcare-providers.html
WebBristol Myers Squibb provides information and resources to healthcare providers (HCP) about our medicines with the goal of improving the health of patients. Discover our HCP resources today.
DA: 5 PA: 12 MOZ Rank: 8
-
Bristol Myers Squibb - News
https://news.bms.com/news/default.aspx
WebApr 8, 2024 · Bristol Myers Squibb Reports First Quarter Financial Results for 2024. 04/22/2024. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster. 04/08/2024.
DA: 3 PA: 23 MOZ Rank: 51
-
Bristol Myers Squibb - U.S. Food and Drug Administration …
https://news.bms.com/news/details/2022/U.S.-Food-and-Drug-Administration-Approves-Sotyktu-deucravacitinib-Oral-Treatment-for-Adults-with-Moderate-to-Severe-Plaque-Psoriasis/default.aspx
Web09/09/2022. Category: Corporate/Financial News. Bristol Myers Squibb’s Sotyktu, a first-in-class, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, is the only approved TYK2 inhibitor worldwide and the first innovation in oral treatment for moderate-to-severe plaque psoriasis in nearly 10 years. website
website
DA: 59 PA: 40 MOZ Rank: 85
-
Advances in cardiovascular disease - Bristol Myers Squibb
https://annual-report.bms.com/2021/our-science/advances-in-cardiovascular-disease.html
WebFor more than 60 years, Bristol Myers Squibb has pioneered the science behind many of the game-changing advances in cardiovascular disease. As we have worked to bring forward new and transformative therapies for patients, our life-saving medicines have benefited millions of people around the world. We continue that work today.
DA: 40 PA: 69 MOZ Rank: 72
-
Annual Report 2023 - Bristol Myers Squibb
https://annual-report.bms.com/
WebFortunately, we are in a time of unprecedented medical and scientific breakthroughs, and Bristol Myers Squibb is at the forefront of this innovation. We are committed to discovering, developing and delivering transformational medicines in disease areas where we believe we can make a meaningful difference — and we made strong progress in 2023.
DA: 34 PA: 80 MOZ Rank: 65